BRIEF-European regulators recommends approval of Gilead's new HIV treatment

* EU Medicines Agency recommends approval of Biogen Inc and AbbVie Inc's daclizumab to treat multiple sclerosis
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.